CoreLine Soft Co

CoreLine Soft Co CROIC

The Cash Return on Invested Capital (CROIC) of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is -82.60 %. In the previous year, Cash Return on Invested Capital (CROIC) was -71.15 % — a change of 16.10% (lower).

CROIC

-82.60 %

YoY

16.10%

Last updated:

Cash Return on Invested Capital (CROIC) of CoreLine Soft Co is 2025 -82.60 % . Cash Return on Invested Capital (CROIC) of CoreLine Soft Co was 2024 -71.15 % . It decreases by 16.10% lower compared to the previous year.

The CoreLine Soft Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2020
-35.81 KRW
Jan 1, 2021
-63.91 KRW
Jan 1, 2022
-308.02 KRW
Jan 1, 2023
-79.57 KRW
Jan 1, 2024
-71.15 KRW
Jan 1, 2025
-82.60 KRW
The CoreLine Soft Co CROIC history
YEARCROICYoY
-82.60 %+16.10%
-71.15 %-10.59%
-79.57 %-74.17%
-308.02 %+381.96%
-63.91 %+78.45%
-35.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

Cash Return on Invested Capital (CROIC) of CoreLine Soft Co is -82.60 % in 2025.

Cash Return on Invested Capital (CROIC) of CoreLine Soft Co changed from -71.15 % to -82.60 %, representing a 16.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s CoreLine Soft Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co